Glenn Whaley
CIK 1724623 · Chief Financial Officer · last filed 2025-07-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.32M
Companies
2
Total Filings
24
Lifetime Open-Market Net
$124.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMUX | Chief Financial Officer | 95,510 | $13.86 | $1.32M | $124.4K | 22 | 2025-07-18 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | VP of Fin, PAO & Controller | 3,616 | — | — | $0 | 2 | 2018-08-10 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-30 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2020-01-10 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2018-08-10 | PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Tax (F) | −84 | -$156 | EDGAR |
| 2018-03-16 | PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Grant (A) | +2,600 | $0 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.